RESUMEN
A combined vaccination schedule using commercial antirabies immunoglobulin G and experimental vaccine from strains Vnukovo-32 or Yuli beginning 2 hr before intracerebral (i.c.) challenge with a high dose of Yuli virus conferred no protection to Cercopithecus aethiops monkeys. In monkeys inoculated into lip with a middle dose of Yuli virus, administration of large amounts of antirabic IgG (up to 5000 national units, NU/kg) had a clearcut effect. The disease in Yuli virus-infected monkeys showed typical signs of acute encephalitis with lethal outcome, although one animal which developed typical encephalitis recovered as evidenced by increased virus-neutralizing antibodies in its serum. Inflammatory and degenerative lesions developed in the CNS of animals with signs of acute encephalomyelitis; their intensity was less prominent in those monkeys which underwent the combined treatment. In the cytoplasm of brain neurons of monkeys infected with Yuli virus relatively small Babes-Negri bodies with more or less apparent internal structure were detected.
Asunto(s)
Inmunoglobulina G/inmunología , Vacunas Antirrábicas/inmunología , Virus de la Rabia/inmunología , Animales , Antígenos Virales/inmunología , Chlorocebus aethiops , Rabia/patología , Rabia/prevención & controlRESUMEN
Two strains (UB-1 and UB-2) of rabies-related viruses were isolated from the brain of Nyctalus noctula and Vespertilio murinus captured from the hollows of tall trees on the left bank of Pripyat river in the Volynsky region of Ukrainian S.S.R. The viruses were isolated by means of intracerebral inoculation to white mice. The isolates were identified as rabies-related viruses of Duvenhage type in an indirect test of fluorescent antibodies with the panels of nucleocapsid monoclonal antibodies (NC Mab) provided by Wistar Institute (Philadelphia) and by Central Veterinary Laboratory (CVL, Weybridge). During the typing with the Wistar panel of NC Mab complete antigenic similarity was established between the newly isolated strain and Yuli virus. The reaction with CVL NC Mab revealed group-specific antigenic similarity between Yuli virus on one hand, Duvenhage-6 and Duvenhage-66 on the other hand, as well as between UB-1 and UB-2 and Duvenhage-26. The reaction with antibodies to clones DB-3,4,6,9, and 10 detected antigenic similarity between the viruses of chiropteric origin isolated in the U.S.S.R., North-West Europe as well in Africa, although some differences were discovered. Yuli, UB-1, and UB-2 viruses isolated in the U.S.S.R. were proved to belong to Duvenhage group of viruses (serotype 4).
Asunto(s)
Quirópteros/microbiología , Virus de la Rabia/aislamiento & purificación , Rabia/microbiología , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Antivirales/inmunología , Ratones , Virus de la Rabia/clasificación , Virus de la Rabia/inmunología , UcraniaRESUMEN
Yuli virus was isolated by intracerebral (i.c.) inoculation of suckling mice with a 10% brain suspension from 11-year-old patient who died under signs of atypical hydrophobia after a bat bite into lower lip. Identification with a panel of monoclonal antibodies (MoAb) to nucleocapsid protein (NP) confirmed that Yuli virus belongs to Lyssavirus genus, as an antigenic variant of the European Duvenhage virus.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Virus de la Rabia/aislamiento & purificación , Rabia/microbiología , Animales , Mordeduras y Picaduras , Encéfalo/microbiología , Encéfalo/patología , Cápside/inmunología , Niño , Quirópteros , Cricetinae , Encefalitis/complicaciones , Encefalitis/diagnóstico , Humanos , Labio/microbiología , Ratones , Rabia/complicaciones , Virus de la Rabia/inmunología , Proteínas del Núcleo Viral/inmunologíaRESUMEN
Tissue culture rabies vaccine has been used for subcutaneous immunization of 158 subjects according to official instructions and also for intramuscular immunization of 128 subjects according to a short schedule with booster inoculations. All 286 subjects were either bitten or contaminated with saliva of rabid animals or animals suspected of having rabies. The 1168 serum samples were tested by neutralization test (NT) in mice, by radial haemolysis (RH) and by indirect haemagglutination (IHA). The highest, earliest and longest active post-vaccination immunity was registered after the most intensive subcutaneous vaccination course at a dose of 5 ml for 25 days with 3 booster inoculations. Subcutaneous inoculation of 3 ml vaccine for 12 days (36 ml) failed to produce a satisfactory elevation of antibody titre. After 2 to 4 booster inoculations, however, a satisfactory level of antibody was observed. The tissue culture vaccine was shown to have good prospects for clinical vaccination by intramuscular route. On intramuscular vaccination at 1.5 ml for 9 days with 6 booster inoculations on days 16, 23, 30, 37, 67 and 97 (initial vaccine volume 45 ml) the mean geometric antibody titres (MGT) reached 93, 160, 322 and 165 on days 30, 60, 90 and 112, respectively. The economically efficient and rapid IHA and RH tests were confirmed to be specific and suitable for titration of antirabies antibody.